Open Access. Powered by Scholars. Published by Universities.®
- Institution
- Publication
- Publication Type
Articles 1 - 7 of 7
Full-Text Articles in Law
Mid-Atlantic Ethics Committee Newsletter, Fall-Winter 1999
Mid-Atlantic Ethics Committee Newsletter, Fall-Winter 1999
Mid-Atlantic Ethics Committee Newsletter
No abstract provided.
Mid-Atlantic Ethics Committee Newsletter, Summer 1999
Mid-Atlantic Ethics Committee Newsletter, Summer 1999
Mid-Atlantic Ethics Committee Newsletter
No abstract provided.
Mid-Atlantic Ethics Committee Newsletter, Spring 1999
Mid-Atlantic Ethics Committee Newsletter, Spring 1999
Mid-Atlantic Ethics Committee Newsletter
No abstract provided.
Bajakajian: New Hope For Escaping Excessive Fines Under The Civil False Claims Act, Melissa Ballengee Alexander
Bajakajian: New Hope For Escaping Excessive Fines Under The Civil False Claims Act, Melissa Ballengee Alexander
Faculty Articles
No abstract provided.
Is It Worth The Trouble? The New Policy On Dissemination Of Information On Off-Label Use Under The Food And Drug Administration Modernization Act Of 1997, Elizabeth Weeks Leonard
Is It Worth The Trouble? The New Policy On Dissemination Of Information On Off-Label Use Under The Food And Drug Administration Modernization Act Of 1997, Elizabeth Weeks Leonard
Scholarly Works
On January 14, 1998 the Food and Drug Administration (FDA) approved the use of a product previously marketed as Excedrin Extra Strength® for use in treating migraine headaches. As part of the approval for the new use of the product, FDA required the pharmaceutical manufacturer of Excedrin®, Bristol-Myers Squibb, to relabel and repackage the product. The new product is called “Excedrin Migraine®” and is sold side-by-side with Excedrin Extra Strength®. Both over-the-counter (OTC) products contain the same active ingredients: 250 milligrams of acetaminophen, 250 milligrams of aspirin, and sixty-five milligrams of caffeine. Many …
Redland Soccer Club, Inc. V. Department Of The Army: The Recovery Of Medicial Monitoring Costs Under Hsca's Citizen Suit Provision, Craig A. Stevens
Redland Soccer Club, Inc. V. Department Of The Army: The Recovery Of Medicial Monitoring Costs Under Hsca's Citizen Suit Provision, Craig A. Stevens
Villanova Environmental Law Journal
No abstract provided.
Twerski & Cohen's Second Revolution: A Systems/Strategic Perspective, Lynn M. Lopucki
Twerski & Cohen's Second Revolution: A Systems/Strategic Perspective, Lynn M. Lopucki
UF Law Faculty Publications
In an article published in 1992, Professors Twerski and Cohen suggested that basic principles of the law of informed consent require medical providers to tell their patients about competing providers could perform the same procedures better or more safely. In its 1996 decision in Johnson v. Kokemoor, the Supreme Court of Wisconsin cited Twerski and Cohen's article in holding a neurosurgeon liable for not telling a patient of such a competitor. As a result, Twerski and Cohen now argue, the law of informed consent now stands on the brink of a second revolution. This comment sets forth a systems/strategic analysis …